Cargando…

Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults

Hepatitis B vaccines are highly effective in preventing hepatitis B virus infection and have been included in the national immunization program of Japan since 2016. Heptavax®-II is one of two hepatitis B vaccine products licensed in Japan, and its manufacturing process is being modified to reduce va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kishino, Hiroyuki, Takahashi, Kenichi, Sawata, Miyuki, Tanaka, Yoshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067840/ https://www.ncbi.nlm.nih.gov/pubmed/29553862 http://dx.doi.org/10.1080/21645515.2018.1452578

Ejemplares similares

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in Japanese healthy adults: A Phase I study
por: Haranaka, Miwa, et al.
Publicado: (2023)

Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly
por: Kawakami, Kenji, et al.
Publicado: (2018)

Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study
por: Murata, Shinya, et al.
Publicado: (2023)

Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028)
por: Ishihara, Yasunori, et al.
Publicado: (2023)

Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants
por: Murata, Shinya, et al.
Publicado: (2020)

Modified recombinant human erythropoietin with potentially reduced immunogenicity
por: Susantad, Thanutsorn, et al.
Publicado: (2021)

Safety, tolerability, and immunogenicity of a novel 4-antigen Staphylococcus aureus vaccine (SA4Ag) in healthy Japanese adults
por: Inoue, Megumi, et al.
Publicado: (2018)

Limited accessibility to designs and results of Japanese large-scale clinical trials for cardiovascular diseases
por: Sawata, Hiroshi, et al.
Publicado: (2011)

Prolonged plasma glucose elevation on oral glucose tolerance test in young healthy Japanese individuals
por: Ishigaki, Hirotaka, et al.
Publicado: (2019)

Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects
por: Oshima, Hiroyuki, et al.
Publicado: (2015)

A Phase 1, Randomized, Placebo‐Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Subcutaneous Tezepelumab in Healthy Japanese Men
por: Sakamoto, Kei, et al.
Publicado: (2020)

Concomitant administration of diphtheria, tetanus, acellular pertussis and inactivated poliovirus vaccine derived from Sabin strains (DTaP-sIPV) with pentavalent rotavirus vaccine in Japanese infants
por: Tanaka, Yoshiyuki, et al.
Publicado: (2017)

A Pharmacokinetic, Safety, and Tolerability Trial of Palovarotene in Healthy Japanese and Non-Japanese Participants
por: Dube, Louise, et al.
Publicado: (2023)

Immunogenicity of Recombinant Hepatitis B Vaccine Among Routinely Vaccinated Healthy and Chronically Ill Children in Assiut, Upper Egypt
por: El-Asheer, Osama M., et al.
Publicado: (2015)

Advances in recombinant antibody manufacturing
por: Kunert, Renate, et al.
Publicado: (2016)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
por: Sakurai, Yuuichi, et al.
Publicado: (2015)

Accelerated oligosaccharide absorption and altered serum metabolites during oral glucose tolerance test in young Japanese with impaired glucose tolerance
por: Miki, Takashi, et al.
Publicado: (2017)

Low Immunogenicity and Immunosuppressive Properties of Human ESC- and iPSC-Derived Retinas
por: Yamasaki, Suguru, et al.
Publicado: (2021)

Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults
por: Kakisaka, Keisuke, et al.
Publicado: (2019)

Phase 1 Dose‐Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Tofacitinib in Japanese Healthy Volunteers
por: Miyoshi, So, et al.
Publicado: (2019)

A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19
por: Nakamura, Keisuke, et al.
Publicado: (2022)

Lactulose Ingestion Induces a Rapid Increase in Genus Bifidobacterium in Healthy Japanese: A Randomised, Double-Blind, Placebo-Controlled Crossover Trial
por: Sakai, Yohei, et al.
Publicado: (2022)

Safety, Tolerability, and Immunogenicity of Interferons
por: Tovey, Michael G., et al.
Publicado: (2010)

Safety and immunogenicity of VGX-3100 formulations in a healthy young adult population
por: Hollenberg, Rebecca K., et al.
Publicado: (2019)

Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers
por: Peters, E, et al.
Publicado: (2015)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Microbial characterization of the Japanese traditional pickle senmaizuke produced by two different manufacturing processes
por: Iguchi, Hiroyuki
Publicado: (2021)

Impact of brown adipose tissue vascular density on body adiposity in healthy Japanese infants and children
por: Kuroiwa, Miyuki, et al.
Publicado: (2021)

Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity
por: Versteeg, Serge A., et al.
Publicado: (2011)

Pharmacokinetic Bioequivalence, Safety, and Immunogenicity of DMB-3111, a Trastuzumab Biosimilar, and Trastuzumab in Healthy Japanese Adult Males: Results of a Randomized Trial
por: Morita, Jun, et al.
Publicado: (2015)

Gastrointestinal Tolerance of an Infant Formula Manufactured from Extensively Hydrolysed Protein in Healthy Term Infants
por: Otten, Lindsey, et al.
Publicado: (2023)

Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women
por: Bagchus, Wilhelmina, et al.
Publicado: (2017)

Four Plasma Glucose and Insulin Responses to a 75 g OGTT in Healthy Young Japanese Women
por: Takahashi, Kei, et al.
Publicado: (2018)

Pharmacokinetics, Safety and Tolerability of Rotigotine Transdermal Patch in Healthy Japanese and Caucasian Subjects
por: Cawello, Willi, et al.
Publicado: (2013)

Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese Participants
por: Barth, Aline, et al.
Publicado: (2022)

Immunogenicity of Catch-Up Immunization with Conventional Inactivated Polio Vaccine among Japanese Adults
por: Fukushima, Shinji, et al.
Publicado: (2022)

Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux Esophagitis in Healthy Young Japanese Volunteers
por: Tanaka, Yuichiro, et al.
Publicado: (2017)

Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedules
por: Agladioglu, S., et al.
Publicado: (2010)

Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study
por: Tomita, Noriko, et al.
Publicado: (2023)

Safety, Tolerability, and Pharmacokinetics of Recombinant Human Neuregulin-1 in Healthy Chinese Subjects
por: Xu, Junyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1uvpnv2of7149uo79hfdijhrsa